Bioprojektai - Company finances
|
EUR
|
2021
From: 2021-01-26
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 5,840 | 34,500 | 2,500 | 29,750 | 19,900 |
| Profit before tax | -29,667 | 64,644 | 1,728 | 21,726 | 5,027 |
| Net profit | -29,667 | 62,895 | 1,642 | 20,640 | 4,725 |
| Equity | -23,366 | 33,328 | 34,869 | 46,610 | 51,335 |
| Liabilities | - | 1,812 | 258 | 1,470 | 302 |
| Non-current assets | 0 | 35,140 | 0 | 0 | 5,750 |
| Current assets | 5,840 | 0 | 35,127 | 48,080 | 45,887 |
| Total assets | 5,840 | 35,140 | 35,127 | 48,080 | 51,637 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 1,899 | 256 | 1,237 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +490.8% | -92.8% | +1090.0% | -33.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -508.0% | 179.0% | 4.7% | 42.9% | 9.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 188.7% | 4.7% | 44.3% | 9.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -508.0% | 182.3% | 65.7% | 69.4% | 23.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -508.0% | 187.4% | 69.1% | 73.0% | 25.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,920 | 29,571 | 2,500 | 29,750 | 19,900 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioprojektai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-02-17 | 2022-02-24 | 44.72 |
| 2022-01-28 | 2022-02-16 | 1.51 |
| 2022-01-18 | 2022-01-18 | 46.83 |
| 2021-11-16 | 2021-11-22 | 1050.05 |
| 2021-11-05 | 2021-11-15 | 0.31 |
Bioprojektai - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-07 | 2026-07-07 | 15.0 |
| 2025-03-07 | 2025-03-31 | 1.0 |
| 2025-02-15 | 2025-03-02 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioprojektai, MB (code 305689342) is a Lithuanian small partnership engaged in the manufacture of soap and detergents, cleaning and polishing preparations. In 2025, the company generated revenue of €19.9K, which was 33.1% lower than in 2024, while net profit amounted to €4.7K. Profitability weakened compared with the previous year, as the net profit margin fell to 23.7% from 69.4% in 2024, but the business remained profitable. The multi-year trajectory shows strong expansion from 2023 to 2024, when revenue increased from €2.5K to €29.8K and net profit rose from €1.6K to €20.6K, followed by a softer 2025. Balance sheet indicators at the end of 2025 remained very solid: total assets were €51.6K, equity €51.3K and liabilities only €302. The equity ratio stood at 99.4%, with debt-to-equity at 0.01, indicating minimal leverage. ROE and ROA were both 9.2%, and asset turnover was 0.39x. Revenue per employee was €19.9K and profit per employee €4.7K.